利拉鲁肽对大鼠急性脊髓损伤后神经细胞自噬与运动功能恢复的作用

李昊天, 赵兴长, 孙平, 王继权, 褚鑫, 吕刚, 范仲凯

李昊天, 赵兴长, 孙平, 王继权, 褚鑫, 吕刚, 范仲凯. 利拉鲁肽对大鼠急性脊髓损伤后神经细胞自噬与运动功能恢复的作用[J]. 解放军医学院学报, 2015, 36(5): 492-496,501. DOI: 10.3969/j.issn.2095-5227.2015.05.022
引用本文: 李昊天, 赵兴长, 孙平, 王继权, 褚鑫, 吕刚, 范仲凯. 利拉鲁肽对大鼠急性脊髓损伤后神经细胞自噬与运动功能恢复的作用[J]. 解放军医学院学报, 2015, 36(5): 492-496,501. DOI: 10.3969/j.issn.2095-5227.2015.05.022
LI Haotian, ZHAO Xingzhang, SUN Ping, WANG Jiquan, CHU Xin, LYU Gang, FAN Zhongkai. Effect of Liraglutide on neuronal autophagy and movements recovery after spinal cord injury in rats[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2015, 36(5): 492-496,501. DOI: 10.3969/j.issn.2095-5227.2015.05.022
Citation: LI Haotian, ZHAO Xingzhang, SUN Ping, WANG Jiquan, CHU Xin, LYU Gang, FAN Zhongkai. Effect of Liraglutide on neuronal autophagy and movements recovery after spinal cord injury in rats[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2015, 36(5): 492-496,501. DOI: 10.3969/j.issn.2095-5227.2015.05.022

利拉鲁肽对大鼠急性脊髓损伤后神经细胞自噬与运动功能恢复的作用

基金项目: 

国家自然科学基金项目(81272074);辽宁省高等学校优秀人才支持计划项目(LJQ2014091);辽宁医学院校长基金(AH2014012;XZJJ20130204)

详细信息
    作者简介:

    李昊天,男,在读硕士。研究方向:脊髓损伤。Email:lhtlacus@163.com

    通讯作者:

    吕刚,男,主任医师,教授,博士生导师。Email:ganglv_jz@163.com

    范仲凯,男,副教授,硕士生导师。Email:flanzz@163.com

  • 中图分类号: R 338

Effect of Liraglutide on neuronal autophagy and movements recovery after spinal cord injury in rats

Funds: 

Supported by the National Natural Science Foundation of China (81272074), Program for Liaoning Excellent Talents in University (2014091), Aohongboze Graduate Sci-tech Innovation Foundation, the President Fund of Liaoning Medical University(AH2014012, XZJJ20130204)

  • 摘要: 目的 探讨利拉鲁肽注射液(Liraglutide)对急性脊髓损伤(spinal cord injury,SCI)后神经细胞的保护作用及其可能机制。 方法 54只SD大鼠随机分成假手术组(Sham组)、脊髓损伤组(SCI组,损伤后立即腹腔注射0.9%氯化钠注射液50μg/kg)和治疗组(Liraglutide组,损伤后立即腹腔注射利拉鲁肽50μg/kg),每组18只,Allen法建立大鼠脊髓损伤模型,于损伤后3 d取脊髓组织,Western blot检测LC3-Ⅱ、Caspase-3表达,免疫荧光双标染色观察神经元自噬表达水平、神经细胞凋亡情况;于损伤后1 d、3 d、7 d分别进行Basso Beattle Bresnahan (BBB)运动评分。 结果 与Sham组相比,SCI组LC3-Ⅱ、Caspase-3表达、自噬阳性神经细胞数目、神经细胞凋亡数目均增多(P< 0.01),BBB评分显著降低(P< 0.01);Liraglutide组与SCI组相比,LC3-Ⅱ显著增多,Caspase-3表达降低(P< 0.01);免疫荧光双标染色示自噬阳性细胞数目明显增多(P< 0.01);神经元凋亡双标染色法示神经凋亡细胞数目明显减少(P< 0.01);BBB评分在3 d与7 d时有显著提高(P< 0.01)。 结论 利拉鲁肽增强大鼠脊髓损伤后神经细胞自噬,降低凋亡相关蛋白表达,减少神经细胞凋亡,促进大鼠运动功能恢复,对脊髓损伤具有保护作用。
    Abstract: Objective To explore the neuroprotective effect and possible mechanism of Liraglutide in the rat model of spinal cord injury (SCI). Methods Fifty-four SD rats were randomly divided into three groups:sham operation group (n=18), spinal cord injury (SCI) group (immediately received 50μg/kg saline injection intraperitoneally after injury, n=18) and Liraglutide group (immediately received 50μg/kg Liraglutide injection intraperitoneally after injury, n=18). Spinal cord injury model was established using Allen's method. The rats were sacrificed and the spinal cord tissue were taken out 3 days after injury. Western blot was used to analyze the LC3-Ⅱ and caspase-3 expression. Immunofluorescent double labeling was used to detect the autophagy positive neurons and neuronal apoptosis. Finally, behavioral assessment with Basso Beattle Bresnahan locomotor rating scale (BBB) was done at 1 d, 3 d and 7 d after injury. Results Compared with sham group, the expression of LC3-Ⅱ, the level of caspase-3 and the number of autophagy positive neurons and neuronal apoptosis increased significantly in SCI group (P< 0.01), while the BBB score decreased significantly (P< 0.01). Furthermore, compared with SCI group, Western blot showed that the expression of LC3-Ⅱincreased while the level of caspase-3 decreased in Liraglutide group (P< 0.01). Immunofluorescent double labeling showed that the number of autophagy positive neurons enhanced significantly (P< 0.01) and the neuronal apoptosis in Liraglutide group reduced significantly compared with SCI group (P< 0.01). Finally, behavioral assessment showed that animals in Liraglutide group achieved significant increase in BBB score on 3 d and 7 d (P< 0.01). Conclusion Liraglutide promotes neuronal autophagy, decreases neuronal apoptosis and improves the locomotor function after SCI. Liraglutide may be a new candidate for clinical application in the treatment of SCI.
计量
  • 文章访问数:  15
  • HTML全文浏览量:  1
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-11-30
  • 网络出版日期:  2023-11-26

目录

    /

    返回文章
    返回